Half of trials supporting FDA applications go unpublished
Over half of all supporting trials for FDA-approved drugs remained unpublished 5 years after approval, says new research published in this week's PLoS Medicine. The most important trials determining efficacy, and those with s ...
Sep 23, 2008
4 / 5 (1) 1